澳华内镜
(688212)
| 流通市值：58.92亿 | | | 总市值：58.92亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 422,626,267.1 | 260,343,298.18 | 123,727,829.72 | 749,549,531.34 |
| 营业收入 | 422,626,267.1 | 260,343,298.18 | 123,727,829.72 | 749,549,531.34 |
| 二、营业总成本 | 520,122,461.5 | 323,582,481.41 | 166,577,607.61 | 767,016,745.83 |
| 营业成本 | 166,884,838.65 | 97,919,241.42 | 41,624,998.3 | 238,927,723.27 |
| 税金及附加 | 3,096,748.88 | 2,039,024.82 | 1,223,340.76 | 5,674,035.31 |
| 销售费用 | 162,091,374.6 | 100,259,482.63 | 52,341,423.37 | 250,203,776.88 |
| 管理费用 | 73,415,133.3 | 50,371,464.65 | 29,968,260.49 | 108,532,136.56 |
| 研发费用 | 113,605,753.86 | 73,809,124.36 | 41,759,818.78 | 163,598,045.33 |
| 财务费用 | 1,028,612.21 | -815,856.47 | -340,234.09 | 81,028.48 |
| 其中:利息费用 | 4,685,343.09 | 2,986,936.88 | 1,009,320.52 | 1,936,192.11 |
| 其中:利息收入 | 2,066,823.21 | 1,465,245.65 | 629,434.09 | 2,450,422.79 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 3,885,207.62 |
| 加:投资收益 | 178,525.38 | -44,505.28 | -190,749.55 | 6,355,758.84 |
| 资产处置收益 | 286,288.69 | 282,797.16 | -5,373.88 | 260,425.7 |
| 资产减值损失(新) | -7,393,339.99 | -7,179,697.06 | -3,642,234.39 | -23,981,611.25 |
| 信用减值损失(新) | -9,521,877.64 | -8,144,791.3 | -2,335,768.29 | -13,663,274.97 |
| 其他收益 | 29,764,176.07 | 26,362,764.09 | 11,336,316.23 | 51,654,441.49 |
| 四、营业利润 | -84,182,421.89 | -51,962,615.62 | -37,687,587.77 | 7,043,732.94 |
| 加:营业外收入 | 4,690.83 | 4,690.76 | 2,344.26 | 212,089.22 |
| 减:营业外支出 | 224,356.42 | 411.42 | 183.83 | 829,496.81 |
| 五、利润总额 | -84,402,087.48 | -51,958,336.28 | -37,685,427.34 | 6,426,325.35 |
| 减:所得税费用 | -28,496,681.07 | -11,050,177.12 | -8,879,820.56 | -13,897,043.77 |
| 六、净利润 | -55,905,406.41 | -40,908,159.16 | -28,805,606.78 | 20,323,369.12 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -55,905,406.41 | -40,908,159.16 | -28,805,606.78 | 20,323,369.12 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -56,092,473.78 | -40,765,239.09 | -28,791,459.68 | 21,012,248.88 |
| 少数股东损益 | 187,067.37 | -142,920.07 | -14,147.1 | -688,879.76 |
| 扣除非经常损益后的净利润 | -68,101,090.89 | -51,754,542.32 | -31,001,057.12 | -6,286,152.9 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.42 | -0.3 | -0.21 | 0.16 |
| (二)稀释每股收益 | -0.42 | -0.3 | -0.21 | 0.16 |
| 八、其他综合收益 | 5,987,970.06 | 6,500,273.67 | 1,956,247.66 | -2,386,147.77 |
| 归属于母公司股东的其他综合收益 | 5,987,970.06 | 6,500,273.67 | 1,956,247.66 | -2,386,147.77 |
| 九、综合收益总额 | -49,917,436.35 | -34,407,885.49 | -26,849,359.12 | 17,937,221.35 |
| 归属于母公司股东的综合收益总额 | -50,104,503.72 | -34,264,965.42 | -26,835,212.02 | 18,626,101.11 |
| 归属于少数股东的综合收益总额 | 187,067.37 | -142,920.07 | -14,147.1 | -688,879.76 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-18 | 2025-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |